U.S., March 5 -- ClinicalTrials.gov registry received information related to the study (NCT06856928) titled 'Impact of Antiobesity Medications on Appetite and Appetite-related Hormones and Metabolites.' on Feb. 13.
Brief Summary: This study aims to explore how anti-obesity medications (AOMs) like semaglutide and tirzepatide affect appetite and energy intake. Researchers will examine two groups: one just starting AOMs and another that has already achieved significant weight loss and maintained it. By conducting meal challenges at different stages of medication use, the study will assess feasibility of the methods and gather preliminary data to design a larger, future study.
Study Start Date: March, 2025
Study Type: OBSERVATIONAL
Conditio...